Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma

Prognostic value of circulating tumour DNA during post‐radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma

Abstract Background The potential of circulating tumour DNA (ctDNA) as a reliable biomarker for relapse/metastasis early detection and prognosis in esophageal squamous cell carcinoma (ESCC) after radiotherapy/chemoradiotherapy (RT/CRT) initiation requires comprehensive investigation. Methods Treatme...

Full description

Bibliographic Details
Main Authors:	Xin Wang, Nuo Yu, Guowei Cheng, Tao Zhang, Jianyang Wang, Lei Deng, Jiao Li, Xiaotian Zhao, Yang Xu, Peng Yang, Na Bai, Yin Li, Nan Bi
Format:	Article
Language:	English
Published:	Wiley 2022-11-01
Series:	Clinical and Translational Medicine
Subjects:	chemoradiotherapy circulating tumour DNA dynamic monitoring esophageal squamous cell carcinoma prognosis radiotherapy
Online Access:	https://doi.org/10.1002/ctm2.1116

Similar Items

The Impact of Radiotherapy Dose in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy
by: Chien-Ming Lo, et al.
Published: (2021-03-01)

Sequential boost of intensity‐modulated radiotherapy with chemotherapy for inoperable esophageal squamous cell carcinoma: A prospective phase II study
by: Xing‐Wen Fan, et al.
Published: (2020-04-01)

Effectiveness of image‐guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy
by: Yao‐Hung Kuo, et al.
Published: (2020-01-01)

Novel Photodynamic Therapy for Esophageal Squamous Cell Carcinoma following Radiotherapy
by: Takumi Yanagita, et al.
Published: (2023-05-01)

Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting
by: Li-Qing Li, et al.
Published: (2022-03-01)

Malignant Broncho-Oesophageal Fistula following Radiotherapy for Noninvasive T3 Oesophageal Squamous Cell Carcinoma
by: Dwayne Reading, et al.
Published: (2022-05-01)

Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma
by: Haishan Wu, et al.
Published: (2021-10-01)

High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: an endemic area population-based study
by: Chia-Chin Li, et al.
Published: (2022-11-01)

Optimal radiotherapy dose in cervical esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy: A population based study
by: Chia‐Chin Li, et al.
Published: (2021-07-01)

Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
by: Bingwen Zou, et al.
Published: (2020-03-01)

Current and future on definitive concurrent chemoradiotherapy for inoperable locally advanced esophageal squamous cell carcinoma
by: Renxian Xie, et al.
Published: (2024-01-01)

A combined predicting model for benign esophageal stenosis after simultaneous integrated boost in esophageal squamous cell carcinoma patients (GASTO1072)
by: Weitong Liu, et al.
Published: (2022-12-01)

Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study
by: Xing Gao, et al.
Published: (2022-05-01)

The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma
by: Song T, et al.
Published: (2020-03-01)

Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy
by: Junchao Qian, et al.
Published: (2022-04-01)

Addition of camrelizumab to docetaxel, cisplatin, and radiation therapy in patients with locally advanced esophageal squamous cell carcinoma: a phase 1b study
by: Wencheng Zhang, et al.
Published: (2021-01-01)

Clinical Application of Oral Meglumine Diatrizoate Esophagogram in Screening for Esophageal Fistula During Radiotherapy or Chemoradiotherapy for Esophageal Cancer
by: Rong Wu, et al.
Published: (2020-10-01)

Chemoradiotherapy with paclitaxel liposome plus cisplatin for locally advanced esophageal squamous cell carcinoma: A retrospective analysis
by: Qiong Yi, et al.
Published: (2023-03-01)

Primary tumor regression patterns in esophageal squamous cell cancer treated with definitive chemoradiotherapy and implications for surveillance schemes
by: Chen M, et al.
Published: (2019-04-01)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
by: Weiming Han, et al.
Published: (2022-11-01)

Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?
by: Xu Yaping, et al.
Published: (2012-08-01)

Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study
by: Takeshi Kawakami, et al.
Published: (2018-05-01)

Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy
by: Tzu-Hui Pao, et al.
Published: (2020-09-01)

Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model
by: Xu Cheng, et al.
Published: (2023-10-01)

Outcomes and prognostic factors for patients with cervical esophageal cancer undergoing definitive radiotherapy or chemoradiotherapy
by: Xin-xin Du, et al.
Published: (2019-05-01)

Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial designCentral MessagePerspective
by: Yuyan Zheng, MD, et al.
Published: (2022-03-01)

Factors affecting survival in esophageal squamous cell carcinoma: Single-center experience
by: Abdullah Sakin, et al.
Published: (2020-05-01)

Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer
by: Tzu-Hui Pao, et al.
Published: (2020-02-01)

Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
by: Ying-Ying Xu, et al.
Published: (2021-07-01)

Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
by: Mingqiu Chen, et al.
Published: (2018-08-01)

The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy
by: Yen-Hao Chen, et al.
Published: (2018-08-01)

Neoadjuvant chemoradiotherapy with camrelizumab in patients with locally advanced esophageal squamous cell carcinoma
by: Fei Chen, et al.
Published: (2022-08-01)

Long-term Prognosis Analysis and Influencing Factors of Concurrent Chemotherapy and Radio-therapy for Cervical and Upper Thoracic Esophageal Squamous Cell Carcinoma
by: YAN Ke, WEI Wanyi, DENG Wenzhao, SHEN Wenbin, LI Shuguang, DU Xingyu, ZHANG Xueyuan, YANG Jie, ZHU Shuchai
Published: (2023-10-01)

Delayed postoperative radiotherapy might improve the long-term prognosis of locally advanced esophageal squamous cell carcinoma
by: Ming-qiang Lin, et al.
Published: (2021-01-01)

The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
by: Qirong Man, et al.
Published: (2024-04-01)

Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma
by: Toshiki Ikawa, et al.
Published: (2019-08-01)

Predicting the efficacy of radiotherapy for esophageal squamous cell carcinoma based on enhanced computed tomography radiomics and combined models
by: Jihui Liu, et al.
Published: (2023-03-01)

Individualized treatment decision model for inoperable elderly esophageal squamous cell carcinoma based on multi-modal data fusion
by: Yong Huang, et al.
Published: (2023-10-01)

Dosimetric analysis and biological evaluation between proton radiotherapy and photon radiotherapy for the long target of total esophageal squamous cell carcinoma
by: Yongbin Cui, et al.
Published: (2022-10-01)

Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma
by: Xiaofei Zhang, et al.
Published: (2018-12-01)